Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In collaboration with Cambodian authorities, MORU are running the Village Drama Against Malaria project for the third year. The project, which runs in 10 remote villages in March 2018, aims to create awareness about malaria prevention and early treatment.

Children in a play

In collaboration with Cambodian authorities and a local Cambodia theatre group, MORU are running the Village Drama Against Malaria project in Siem Pang district, Stung Treng province. This is the third year we are running this project. The project runs from 25th Feb to 29th March 2018 and will be in 10 villages, some of them very remote farming villages with close to the border with Laos along the Sikong river. Most of these villages are remote and populated by Lao and other ethnic minority peoples. 

The aim of the project is to create awareness about malaria prevention and early treatment; and infant vaccination using art and theater as engagement tools and leveraging traditional ethnic arts.

The theatre group goes from one village to another conducting art and theatre workshops with village children and young people. They also invite villagers to share their traditional tools, costumes. arts and dances. On the third evening, there is a public performance at the village square where there are games, singing competitions, malaria quizzes, and a comedy sketch about malaria – performed by village children.

The project is led by Nou Sanann (Public Engagement Officer) with support from Pich Kunthea, Tom Peto, Rupam Tripura, James Callery and Phaik Yeong Cheah, and is funded by a Wellcome Trust Provision for Public Engagement grant (supplement).

Similar stories

Antimalarial chemoprophylaxis for forest goers could help accelerate malaria elimination in Cambodia

Giving people antimalarials during and after visiting the forest reduced their risk of contracting malaria 6-fold, and could be the missing piece towards eliminating malaria in Asia-Pacific and South America, say Mahidol and Oxford University researchers in a study published in The Lancet Infectious Diseases.

OUCRU presents a new virtual exhibition: Digital Diaries, Voices from the Pandemic, COVID-19 experiences in Asia

This online exhibition showcases short films and photographs created by health-care workers and community members and documents the socio-cultural impact of the COVID-19 pandemic in Indonesia, Nepal and Vietnam.

Four CTMGH researchers awarded full professorships

We are delighted to announce that four of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine, University of Oxford.

INTERBIO-21st study findings could help predict infants at risk of obesity

Fetal abdomen growth and the mother’s blood fat metabolites very early in pregnancy influence a child’s weight, body fat, vision and neurodevelopment at 2 years of age

Using mathematical modelling to fight malaria

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.

MORU hepatitis work focusses on preventing mother-to-child transmission, high-at-risk populations, and remote communities

MORU Tropical Health Network researchers in Southeast Asia study various aspects of hepatitis B and C, infections that can lead to chronic liver diseases, and complications like liver cancer or cirrhosis. Researchers at MOCRU work on treatment for hepatitis C, a frequent opportunistic infection in HIV patients. MORU’s Clinical Pharmacology conducts two trials on possible treatments of hepatitis C. Hepatitis B is frequently transmitted from mother to child at birth, and SMRU researchers study mothers’ knowledge and behaviour, as well as prevention.